Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistance, Neoplasm | 3 | 2024 | 5329 | 0.420 |
Why?
|
| Neoplasms | 9 | 2024 | 22350 | 0.400 |
Why?
|
| Tumor Burden | 2 | 2025 | 1900 | 0.310 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 2039 | 0.290 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 5 | 2025 | 5387 | 0.290 |
Why?
|
| Adenocarcinoma | 2 | 2023 | 6359 | 0.260 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2024 | 3607 | 0.260 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2023 | 3666 | 0.240 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 9525 | 0.220 |
Why?
|
| Mutation | 11 | 2024 | 30213 | 0.220 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2024 | 212 | 0.210 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2023 | 102 | 0.190 |
Why?
|
| Lung Neoplasms | 5 | 2025 | 13485 | 0.190 |
Why?
|
| Hematology | 1 | 2023 | 243 | 0.160 |
Why?
|
| Mice, SCID | 1 | 2024 | 2628 | 0.160 |
Why?
|
| Nevus, Blue | 1 | 2019 | 43 | 0.160 |
Why?
|
| Cholangiocarcinoma | 1 | 2024 | 562 | 0.160 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2019 | 103 | 0.160 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2023 | 790 | 0.130 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2025 | 2028 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2024 | 5690 | 0.120 |
Why?
|
| Endometrial Neoplasms | 1 | 2024 | 1380 | 0.120 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 1673 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2024 | 2823 | 0.100 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 2184 | 0.090 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 1926 | 0.090 |
Why?
|
| Genome, Human | 1 | 2023 | 4443 | 0.090 |
Why?
|
| Phosphoproteins | 1 | 2019 | 2448 | 0.090 |
Why?
|
| Humans | 22 | 2025 | 766766 | 0.070 |
Why?
|
| Middle Aged | 9 | 2025 | 223257 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 59550 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 4904 | 0.070 |
Why?
|
| Aged | 7 | 2025 | 171343 | 0.060 |
Why?
|
| Adult | 6 | 2025 | 223307 | 0.060 |
Why?
|
| Female | 10 | 2025 | 396520 | 0.060 |
Why?
|
| Ascitic Fluid | 1 | 2023 | 189 | 0.050 |
Why?
|
| Disease Progression | 1 | 2020 | 13640 | 0.050 |
Why?
|
| Quinoxalines | 1 | 2024 | 297 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2024 | 54871 | 0.050 |
Why?
|
| Ascites | 1 | 2023 | 336 | 0.050 |
Why?
|
| Morpholines | 1 | 2024 | 584 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 20708 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2024 | 81635 | 0.050 |
Why?
|
| Melanoma | 1 | 2019 | 5700 | 0.040 |
Why?
|
| Mice | 2 | 2024 | 81889 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2024 | 9404 | 0.040 |
Why?
|
| Microsatellite Instability | 1 | 2024 | 726 | 0.040 |
Why?
|
| Acrylamides | 1 | 2022 | 260 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 5861 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2023 | 716 | 0.040 |
Why?
|
| Prognosis | 3 | 2025 | 29948 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 904 | 0.040 |
Why?
|
| Bile Duct Neoplasms | 1 | 2024 | 614 | 0.040 |
Why?
|
| BRCA2 Protein | 1 | 2023 | 802 | 0.040 |
Why?
|
| Pyrroles | 1 | 2024 | 1121 | 0.040 |
Why?
|
| Male | 6 | 2025 | 364142 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2023 | 1741 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2023 | 1155 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2020 | 23619 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2023 | 2510 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2022 | 1071 | 0.030 |
Why?
|
| Aniline Compounds | 1 | 2022 | 1079 | 0.030 |
Why?
|
| Animals | 2 | 2024 | 168930 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 2060 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2024 | 2030 | 0.030 |
Why?
|
| United States | 1 | 2022 | 72951 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 2881 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2024 | 4891 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1762 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2022 | 6066 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2024 | 3043 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 2056 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2019 | 2901 | 0.020 |
Why?
|
| Contrast Media | 1 | 2024 | 5329 | 0.020 |
Why?
|
| DNA | 1 | 2022 | 7208 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 17088 | 0.020 |
Why?
|
| Genomics | 1 | 2023 | 5923 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 4353 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2023 | 12150 | 0.010 |
Why?
|
| Young Adult | 1 | 2024 | 59939 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2023 | 65273 | 0.010 |
Why?
|
Concepts
(81)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_